Alar Pharmaceuticals Inc.

Established in 2016, Alar Pharmaceuticals Inc. (Alar), a new drug development company, focuses on developing long-acting release injectables (LAIs) for central nervous system (CNS) disorders and chronic diseases, which mainly include opioid use disorder, alcohol use disorder, chronic pain, treatment-resistant depression, and Parkinson’s disease.